Full Text View
Tabular View
No Study Results Posted
Related Studies
Amantadine for Treatment of Symptoms of the Post-Traumatic Confusional State
This study is ongoing, but not recruiting participants.
Study NCT00693121   Information provided by Methodist Rehabilitation Center
First Received: June 4, 2008   Last Updated: June 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Traumatic Brain Injury
Posttraumatic Confusional State
Delirium
Additional conditions recognized in this trial
Brain Injuries
Confusion
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Delirium, Dementia, Amnestic, Cognitive Disorders
Disorders of Environmental Origin
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
Amantadine hydrochloride
Placebo capsule
Additional drug interventions recognized in this trial
Amantadine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Dyskinesia Agents
Anti-Infective Agents
Antiparkinson Agents
Antiviral Agents
Central Nervous System Agents
Dopamine Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Methodist Rehabilitation Center
Department of Education


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services